An international team led by Washington University School of Medicine in St. Louis has selected a third investigational drug to be tested in a worldwide clinical trial – already underway – aimed at finding treatments to prevent Alzheimer’s disease. The third drug is being developed by Janssen Research & Development, LLC, in New Jersey.